Showing results (591-600 of 602) with videos related to

Sort By:
Pageof 61
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter studyJ B Bachet, O Bouché, J Taieb, et al.
The Pharmacogenomics Journal|October 29, 2014
Frequent intragenic rearrangements of DPYD in colorectal tumoursA B P van Kuilenburg, M-C Etienne-Grimaldi, A Mahamat, et al.
Journal of Hepatology|March 22, 2026
Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French Genomic Medicine InitiativeC Campani, P Laurent Puig, F Villeret, et al.
Cell Reports|April 20, 2022
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphomaJose R Cortes, Ioan Filip, Robert Albero, et al.
The Journal of Clinical Investigation|January 4, 2021
DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3Rahul S Bhansali, Malini Rammohan, Paul Lee, et al.
British Journal of Cancer|May 8, 2014
Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic studyM-C Etienne-Grimaldi, A Mahamat, M Chazal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2025
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trialC Lepage, J-M Phelip, L Cany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P Laurent, Aurélie Siret, Cathy Ignacimouttou, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2025
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapyF Poumeaud, T Valentin, N Fares, et al.
Pageof 61